Ajay Kumar Jha
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ajay Kumar Jha has a total of 57 co-authors. Here are the top co-authors by number of shared publications:
Nivedita Jha
From the Department of Anaesthesiology and Critical Care, Jawaharlal Institute of Medical Education and Research (AKJ), and Department of Obstetrics and Gynecology, Jawaharlal Institute of Post Graduate Medical Education and Research, Puducherry, India (NJ)
15 shared publicationsSatyen Parida
Jawaharlal Institute of Postgraduate Medical Education and Research
7 shared publicationsSuman Lata
Department of Anesthesiology and Critical Care , Jawaharlal Institute of Post Graduate Medical Education and Research, Puducherry, India
7 shared publicationsSandeep Kumar Mishra
Department of Anesthesiology and Critical Care, Jawaharlal Institute of Post Graduate Medical Education and Research, Puducherry, India (Raguramane, Mishra, and Parida)
5 shared publications- Nivedita Jha
Department of Obstetrics and Gynecology Jawaharlal Institute of Post Graduate Medical Education and Research Puducherry India
4 shared publications Sundararaj Rajkumar
Department of Anesthesiology and Critical Care, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India
3 shared publications
Latest Publications
- 23 July 2026
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 68 (1) , 2600509
High output heart failure in group 1 pulmonary hypertension and clinical outcomes
Extract This letter is in response to an interesting article published in a recent issue of the European Respiratory Journal by Reddy et al. [1]. The findings of this study are interesting and noteworthy. However, a few physiological justifications are needed to derive a meaningful interpretation. All three pulmonary hypertension phenotypes (low, normal and high cardiac output) had normal ejection fractions and nearly similar mean arterial pressure. In a subset of patients, pulmonary vasodilator therapy increased cardiac output solely by reducing systemic vascular resistance (SVR). Shareable abstract Intensification of diuretic therapy may improve outcomes in high cardiac output pulmonary hypertension https://bit.ly/4bJAJ8d
- 23 July 2026
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 68 (1) , 2600509
High output heart failure in group 1 pulmonary hypertension and clinical outcomes
Extract This letter is in response to an interesting article published in a recent issue of the European Respiratory Journal by Reddy et al. [1]. The findings of this study are interesting and noteworthy. However, a few physiological justifications are needed to derive a meaningful interpretation. All three pulmonary hypertension phenotypes (low, normal and high cardiac output) had normal ejection fractions and nearly similar mean arterial pressure. In a subset of patients, pulmonary vasodilator therapy increased cardiac output solely by reducing systemic vascular resistance (SVR). Shareable abstract Intensification of diuretic therapy may improve outcomes in high cardiac output pulmonary hypertension https://bit.ly/4bJAJ8d
- 1 April 2026
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 36 (3) , 538-544
Effect of preoperative oral iron supplementation on postoperative outcomes in children with acyanotic congenital heart disease undergoing cardiac surgery: a pragmatic randomised clinical trial
Background: Studies assessing the effect of preoperative iron supplementation in paediatric cardiac surgery are limited and yield conflicting data. Objectives: The study aimed to evaluate the effect of preoperative oral iron supplementation on allogeneic blood transfusion after cardiac surgery for acyanotic CHD. Method: This was a prospective, open-label, outcome assessor-blinded, randomised clinical trial performed in a large tertiary care centre in India. Children (haemoglobin p < 0.01). Furthermore, total cumulative allogeneic blood transfusion was also significantly lower in the intervention arm (60 ml; (0–100) vs 100 ml; (70–140); p < 0.001). The duration of mechanical ventilation, ICU stay, and hospital stay was significantly lower in the intervention arm. Conclusion: Preoperative oral iron supplementation significantly reduces the need for allogeneic blood transfusion in children undergoing cardiac surgery for acyanotic heart disease.
- 1 April 2026
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 36 (3) , 538-544
Effect of preoperative oral iron supplementation on postoperative outcomes in children with acyanotic congenital heart disease undergoing cardiac surgery: a pragmatic randomised clinical trial
Background: Studies assessing the effect of preoperative iron supplementation in paediatric cardiac surgery are limited and yield conflicting data. Objectives: The study aimed to evaluate the effect of preoperative oral iron supplementation on allogeneic blood transfusion after cardiac surgery for acyanotic CHD. Method: This was a prospective, open-label, outcome assessor-blinded, randomised clinical trial performed in a large tertiary care centre in India. Children (haemoglobin p < 0.01). Furthermore, total cumulative allogeneic blood transfusion was also significantly lower in the intervention arm (60 ml; (0–100) vs 100 ml; (70–140); p < 0.001). The duration of mechanical ventilation, ICU stay, and hospital stay was significantly lower in the intervention arm. Conclusion: Preoperative oral iron supplementation significantly reduces the need for allogeneic blood transfusion in children undergoing cardiac surgery for acyanotic heart disease.
- 5 August 2025
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 53 (8) , e1712-e1713
Impact of Bundle Branch Block on Mortality in Cardiogenic Shock
- 5 August 2025
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 53 (8) , e1712-e1713
Impact of Bundle Branch Block on Mortality in Cardiogenic Shock
- 5 August 2025
- Published by Wolters Kluwer Health in Circulation
- Vol. 152 (5) , e48-e49
Letter by Jha Regarding Article, “Interatrial Shunt Treatment for Heart Failure: The Randomized RELIEVE-HF Trial”
- 5 August 2025
- Published by Wolters Kluwer Health in Circulation
- Vol. 152 (5) , e48-e49
Letter by Jha Regarding Article, “Interatrial Shunt Treatment for Heart Failure: The Randomized RELIEVE-HF Trial”
- 6 May 2025
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 65 (5) , 2500384
Unravelling the physiology of exercise pulmonary hypertension in patients with heart failure with preserved ejection fraction
Extract This correspondence relates to an interesting article published recently in the European Respiratory Journal by Balmain et al. [1]. The authors should be commended for elucidating the physiological mechanism of exercise pulmonary hypertension in heart failure with preserved ejection fraction (HFpEF). However, I offer a few alternative explanations. First, the increase in pulmonary artery wedge pressure (PAWP) was disproportionately higher in the exaggerated exercise pulmonary hypertension (EePH) group, despite a similar rise in stroke volume and cardiac output (CO) in both groups at all work rates. Furthermore, the increase in mean pulmonary artery pressure (mPAP) of about 30 mmHg was solely due to a rise in PAWP (also of about ∼30 mmHg) during exercise. A higher mPAP/CO slope in EePH may indicate latent pulmonary vascular disease, and exercise may manifest pulmonary hypertension either by increase or no change in pulmonary vascular resistance (PVR) [2, 3]. Shareable abstract Left ventricular compliance and size is the primary driver for exercise-induced pulmonary hypertension due to a disproportionate rise in pulmonary artery wedge pressure https://bit.ly/4iZcSSQ
- 6 May 2025
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 65 (5) , 2500384
Unravelling the physiology of exercise pulmonary hypertension in patients with heart failure with preserved ejection fraction
Extract This correspondence relates to an interesting article published recently in the European Respiratory Journal by Balmain et al. [1]. The authors should be commended for elucidating the physiological mechanism of exercise pulmonary hypertension in heart failure with preserved ejection fraction (HFpEF). However, I offer a few alternative explanations. First, the increase in pulmonary artery wedge pressure (PAWP) was disproportionately higher in the exaggerated exercise pulmonary hypertension (EePH) group, despite a similar rise in stroke volume and cardiac output (CO) in both groups at all work rates. Furthermore, the increase in mean pulmonary artery pressure (mPAP) of about 30 mmHg was solely due to a rise in PAWP (also of about ∼30 mmHg) during exercise. A higher mPAP/CO slope in EePH may indicate latent pulmonary vascular disease, and exercise may manifest pulmonary hypertension either by increase or no change in pulmonary vascular resistance (PVR) [2, 3]. Shareable abstract Left ventricular compliance and size is the primary driver for exercise-induced pulmonary hypertension due to a disproportionate rise in pulmonary artery wedge pressure https://bit.ly/4iZcSSQ
- 5 March 2025
- Published by Wolters Kluwer Health in European Journal of Anaesthesiology
- Vol. 42 (4) , 373-374
Risk of myocardial injury in mean arterial pressure or cardiac index guided intra-operative haemodynamic management
- 5 March 2025
- Published by Wolters Kluwer Health in European Journal of Anaesthesiology
- Vol. 42 (4) , 373-374
Risk of myocardial injury in mean arterial pressure or cardiac index guided intra-operative haemodynamic management
- 15 February 2025
- Published by Elsevier in American Journal of Obstetrics & Gynecology MFM
- Vol. 7 (4) , 101648
Intravenous calcium during spinal anesthesia in women with preeclampsia who are receiving magnesium therapy
- 15 February 2025
- Published by Elsevier in American Journal of Obstetrics & Gynecology MFM
- Vol. 7 (4) , 101648
Intravenous calcium during spinal anesthesia in women with preeclampsia who are receiving magnesium therapy
- 1 February 2025
- Published by American Association of Nurse Anesthesiology in American Association of Nurse Anesthesiology Journal
- Vol. 93 (1) , 39-43
Anesthetic Management and outcomes of pregnant women with Ebstein’s anomaly: Prospective report
Fetomaternal outcomes and anesthetic management of pregnancy have rarely been described in a prospective cohort of women with Ebstein's anomaly. Therefore, due to the scarcity of data, diagnostic approaches and obstetric and anesthetic management plans are still evolving. In this prospective observational study, we describe the anesthetic management and fetomaternal outcomes of seven women with different grades of unrepaired Ebstein's anomaly. All women were in NYHA (New York Heart Association) Class II, none had cyanosis or cardiac decompensation at the time of admission during pregnancy. Pregnancy was uneventful except in one woman who developed pulmonary oedema. Two women developed supraventricular arrhythmia in the postpartum period. Six women underwent vaginal or assisted vaginal delivery, while one woman underwent cesarean delivery due to the transverse lie of the fetus. All mothers returned to NYHA Class I at 6 weeks follow up. In conclusion, pregnancy increases the risk of maternal complications in asymptomatic women with Ebstein's anomaly. Therefore, preoperative functional and echocardiographic risk stratification is crucial for prepregnancy counseling. Intrapartum and postpartum surveillance, prompt diagnosis of complications, and appropriate management in multidisciplinary hospital settings are associated with favorable fetomaternal outcomes.
- 1 February 2025
- Published by American Association of Nurse Anesthesiology in American Association of Nurse Anesthesiology Journal
- Vol. 93 (1) , 39-43
Anesthetic Management and outcomes of pregnant women with Ebstein’s anomaly: Prospective report
Fetomaternal outcomes and anesthetic management of pregnancy have rarely been described in a prospective cohort of women with Ebstein's anomaly. Therefore, due to the scarcity of data, diagnostic approaches and obstetric and anesthetic management plans are still evolving. In this prospective observational study, we describe the anesthetic management and fetomaternal outcomes of seven women with different grades of unrepaired Ebstein's anomaly. All women were in NYHA (New York Heart Association) Class II, none had cyanosis or cardiac decompensation at the time of admission during pregnancy. Pregnancy was uneventful except in one woman who developed pulmonary oedema. Two women developed supraventricular arrhythmia in the postpartum period. Six women underwent vaginal or assisted vaginal delivery, while one woman underwent cesarean delivery due to the transverse lie of the fetus. All mothers returned to NYHA Class I at 6 weeks follow up. In conclusion, pregnancy increases the risk of maternal complications in asymptomatic women with Ebstein's anomaly. Therefore, preoperative functional and echocardiographic risk stratification is crucial for prepregnancy counseling. Intrapartum and postpartum surveillance, prompt diagnosis of complications, and appropriate management in multidisciplinary hospital settings are associated with favorable fetomaternal outcomes.
- 1 February 2025
- Published by Wolters Kluwer Health in Circulation: Heart Failure
- Vol. 18 (2) , e012511
Letter by Jha Regarding Article, “Pathophysiologic Vasodilation in Cardiogenic Shock and Its Impact on Mortality”
- 1 February 2025
- Published by Wolters Kluwer Health in Circulation: Heart Failure
- Vol. 18 (2) , e012511
Letter by Jha Regarding Article, “Pathophysiologic Vasodilation in Cardiogenic Shock and Its Impact on Mortality”